Anfeng Guo

Mr. Anfeng Guo will serve as our Chief Commercial Officer starting from September 2022. With over 20 years of experience in the pharmaceutical industry, Mr. Guo has developed a deep and sharp insight into this field. He was the VP and head of the Oncology Division and Liver Disease Division of BMS, and Senior Director of the Oncology Division of AZ, leading and participating in the listing of products including Opdivo, Tagrisso, Iressa, Baraclude, etc. For the recent two years, Mr. Guo, CCO of Linkdoc, has been leading the team building a digital Ecosystem for the pharmaceutical companys, clinical HCPs and researchers, and patients in the oncology field. Mr. Guo graduated from Nanjing Tech University, majoring in Pharmaceutical Microbiology. He also got a MBA from Nanjing University.

Mr. Anfeng Guo will serve as our Chief Commercial Officer starting from September 2022. With over 20 years of experience in the pharmaceutical industry, Mr. Guo has developed a deep and sharp insight into this field. He was the VP and head of the Oncology Division and Liver Disease Division of BMS, and Senior Director of the Oncology Division of AZ, leading and participating in the listing of products including Opdivo, Tagrisso, Iressa, Baraclude, etc. For the recent two years, Mr. Guo, CCO of Linkdoc, has been leading the team in building a digital Ecosystem for pharmaceutical companies, clinical HCPs and researchers, and patients in the oncology field. Mr. Guo graduated from Nanjing Tech University, majoring in Pharmaceutical Microbiology. He also got MBA from Nanjing University.